What Happened
- India's trade negotiating team is scheduled to visit Washington from April 20–22, 2026, for the next round of discussions on the bilateral trade agreement.
- The visit focuses on finalising the legal language of the interim trade framework announced in February 2026, ahead of a July 2026 deadline when current US tariff provisions expire.
- The February 2026 framework paired Indian tariff reductions and enhanced US purchases (energy, defence) with a planned reduction of US tariffs on Indian goods from 25% to 18%.
- The earlier tariff architecture was struck down by the US Supreme Court in February; the US has since imposed 10% tariffs on India under Section 122 of the Trade Act of 1974, valid only for 150 days until late July 2026.
- Key sticking points include non-tariff barriers, Section 232 (steel and aluminium) and Section 301 (industrial capacity) issues, medical device price regulation, and data localisation rules.
Static Topic Bridges
Bilateral Trade Agreements — Structure and India's Approach
A Bilateral Trade Agreement (BTA) or Free Trade Agreement (FTA) is a treaty between two countries that reduces or eliminates tariffs, quotas, and other barriers to trade in goods and services. India has FTAs with ASEAN (2010), South Korea (2010), Japan (2011), UAE (CEPA, 2022), and Australia (interim ECTA, 2022). India has historically been cautious about comprehensive FTAs, particularly with economies that have large manufacturing surpluses, due to concerns about domestic industry displacement. The India-US trade relationship has never had a formal FTA, though both sides have explored one since at least 2019.
- India is the US's 9th-largest trading partner; the US is India's largest export market
- India's FTA negotiations are led by the Department of Commerce under the Ministry of Commerce and Industry
- Key Indian sensitivities in US negotiations: agricultural market access, dairy, e-commerce, intellectual property enforcement, data localisation
- Key US demands: lower tariffs on industrial goods, removal of price caps on medical devices, greater market access for agriculture, intellectual property strengthening
- Section 122 of the Trade Act of 1974 allows the US President to impose tariffs up to 15% for 150 days without Congressional approval in cases of large or serious trade deficits
Connection to this news: India's delegation to Washington is working to convert the fragile February 2026 framework into a durable legal agreement before the Section 122 authority window closes in late July 2026.
Non-Tariff Barriers (NTBs) — A Persistent Trade Friction
Non-tariff barriers (NTBs) are policy measures other than ordinary customs tariffs that can have trade-distorting effects. They include technical standards and regulations, sanitary and phytosanitary (SPS) measures, import licensing, quotas, local content requirements, and government procurement rules. The US has long argued that India's NTBs — including price controls on medical devices and pharmaceuticals, mandatory data localisation, and complex import standards — restrict market access more than India's formal tariff rates.
- India's Medical Device (Price Control) Order has capped prices of stents, orthopaedic implants, and other devices, affecting US medical device exports significantly
- Data localisation requirements: India's draft Digital Personal Data Protection rules and financial sector regulations require certain data categories to be stored locally, affecting US tech companies
- India's SPS measures on agricultural imports (poultry, dairy) have been a source of dispute
- WTO TBT Agreement (Technical Barriers to Trade) and SPS Agreement provide multilateral frameworks for challenging NTBs
- India removed from US GSP (Generalized System of Preferences) in 2019 partly over medical device pricing and data localisation issues
Connection to this news: The April 2026 Washington talks will need to resolve NTBs alongside tariff questions — these structural issues often prove harder to negotiate than headline tariff rates.
Strategic Dimension of India-US Trade
The India-US trade relationship is increasingly embedded in a broader strategic partnership. Both countries are members of the Quad (Quadrilateral Security Dialogue) and the iCET (Initiative on Critical and Emerging Technology) framework. The US views India as a key partner in supply chain diversification away from China, particularly in semiconductors, pharmaceuticals, and clean energy. India's energy purchases from the US (LNG, crude oil) and defence procurement have been explicitly linked to trade concessions in the 2026 negotiations, reflecting the intertwining of economic and security interests.
- iCET launched 2022: covers semiconductors, AI, quantum computing, space, and defence technology co-production
- Quad (India, US, Japan, Australia): primarily a security forum but increasingly covers supply chain resilience and technology standards
- US-India Defence Technology and Trade Initiative (DTTI) facilitates co-production of defence equipment
- India's LNG purchases from the US have grown significantly; the US aims for India to become a major LNG buyer to reduce India's reliance on Russian energy
Connection to this news: The April trade talks reflect the strategic logic that a trade deal is not merely economic but is meant to institutionalise the broader India-US partnership, making it resilient to political changes in either country.
Key Facts & Data
- India-US goods and services trade: ~$190 billion (FY25)
- February 2026 trade framework: US tariff reduction from 25% to 18% on Indian goods; Indian tariff cuts + enhanced US purchases
- Section 122 tariff authority: 10% tariffs, valid for 150 days from February 24, 2026 (expires late July 2026)
- India delegation to Washington: April 20–22, 2026
- India's FTA partners: ASEAN (2010), South Korea (2010), Japan (2011), UAE (2022), Australia (2022 interim)
- India removed from US GSP: June 2019 ($5.6 billion in annual Indian exports affected)